Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.51 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 11/18/15 All times are local (Market data is delayed by at least 15 minutes).

vansen pharma inc (VNSN) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/15 - $2.00
52 Week Low
04/23/15 - $0.0005
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VANSEN PHARMA INC (VNSN)

Related News

No related news articles were found.

vansen pharma inc (VNSN) Related Businessweek News

No Related Businessweek News Found

vansen pharma inc (VNSN) Details

Vansen Pharma Inc. is engaged in the sale and marketing of specialty pharmaceutical products in the United States. It sells Spectracef, an anti-infective product and its cefditoren pivoxil generic product to wholesalers and pharmacy chains; and FACTIVE tablets for the treatment of acute bacterial exacerbation of chronic bronchitis and mild to moderate community-acquired pneumonia. The company was formerly known as Okana Ventures, Inc. and changed its name to Vansen Pharma Inc. in August 2013. Vansen Pharma Inc. was founded in 2005 and is based in Las Vegas, Nevada.

vansen pharma inc (VNSN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vansen pharma inc (VNSN) Key Developments

Vansen Pharma Inc.’s Common Stock To Be Deleted From OTCBB

Vansen Pharma Inc.’s common stock will be deleted from OTC Bulletin Board (OTCBB) effective May 20, 2014 due to regulatory/non compliance.

Vansen Pharma Inc. will Change its Ticker to VNSN.E from VNSN

Effective April 21, 2014, Vansen Pharma Inc. will change its OTC Bulletin Board stock ticker symbol to VNSN.E from VNSN.

Vansen Pharma Inc. announced delayed annual 10-K filing

On 04/01/2014, Vansen Pharma Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNSN:US $0.51 USD 0.00

VNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VNSN.
View Industry Companies

Industry Analysis


Industry Average

Valuation VNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 53.5x
Price/Book 22.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 62.4x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VANSEN PHARMA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at